Related Experiment Video
Updated: Jul 5, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
Role of decorin in the antimyeloma effects of osteoblasts
Xin Li1, Angela Pennisi, Shmuel Yaccoby
1Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Abstract:
Building on our previous report that osteoblasts and increased bone formation have a negative impact on myeloma cell growth in a subset of patients, we investigated the role of decorin, the main small leucine-rich proteoglycan (SLRP) expressed and produced by osteoblasts, in the antimyeloma effects of osteoblasts. In coculture experiments with osteoblasts, primary myeloma cell survival was significantly higher when decorin expression in osteoblasts was knocked down by short-hairpin RNA. Coculture experiments of myeloma cells and supporting osteoclasts in the presence of osteoblast-conditioned medium showed reduced myeloma cell survival, an effect that was attenuated by decorin-neutralizing antibody. Decorin overexpression in mesenchymal stem cells or use of recombinant decorin in coculture with osteoclasts reduced the ability of osteoclasts to support primary myeloma cell survival. The antimyeloma effect of decorin involved direct induction of apoptosis and activation of p21(WAF). Decorin also inhibited myeloma cell-induced tube formation and osteoclast differentiation. Decorin expression was insignificantly lower in patients' than donors' osteoblasts and slightly increased by bortezomib. Certain SLRPs are involved in the antimyeloma effect of osteoblasts directly and indirectly through inhibition of angiogenesis and osteoclastogenesis; therefore, increasing endogenous or exogenous SLRPs in myelomatous bone may help control myeloma.
Insights
Decorin, a protein from bone-forming osteoblasts, directly inhibits myeloma cell growth and survival. Increasing decorin levels may offer a new strategy for controlling multiple myeloma bone disease.
Area of Science:
- Biochemistry
- Oncology
- Bone Biology
Background:
- Osteoblasts and bone formation negatively impact myeloma cell growth.
- Decorin is a key small leucine-rich proteoglycan (SLRP) produced by osteoblasts.
Purpose of the Study:
- Investigate decorin's role in the antimyeloma effects of osteoblasts.
- Determine decorin's direct and indirect mechanisms against myeloma cells.
Main Methods:
- Coculture experiments with osteoblasts, myeloma cells, and osteoclasts.
- Short-hairpin RNA knockdown and overexpression of decorin.
- Use of decorin-neutralizing antibodies and recombinant decorin.
Main Results:
- Decorin knockdown in osteoblasts increased myeloma cell survival.
- Decorin inhibited osteoclast-supported myeloma cell survival.
- Decorin induced myeloma cell apoptosis, activated p21(WAF), and inhibited angiogenesis and osteoclastogenesis.
Conclusions:
- Decorin mediates osteoblast's antimyeloma effects.
- Decorin directly induces apoptosis and inhibits key processes supporting myeloma.
- Enhancing SLRPs like decorin could be a therapeutic strategy for multiple myeloma.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Matrix Metalloproteases in Degradation of ECM
A...
Bone Remodeling and Repair
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
